35Pharma

Q: What is 35Pharma's official website?

35Pharma's official website is www.35pharma.com

Q: What is 35Pharma's Revenue?

35Pharma's revenue is <$5 Million

Q: What industry does 35Pharma belong to?

35Pharma is in the industry of: Blood & Organ Banks , Business Services , Healthcare Services

Q: What is 35Pharma competition?

35Pharma top competitors include: WaveBreak , ValVention , Aceragen , Qureator

Q: What companies has 35Pharma acquired?

35Pharma has acquired the companies: NovaMin Technology, Aiolos Bio, Elsie Biotechnologies, Sierra Oncology

Q: What technology does 35Pharma use?

Some of the popular technologies that 35Pharma uses are: reCAPTCHA, Cloudflare Website Optimization, Cloudflare CDN, WordPress.com

Q: What does 35Pharma do?

35Pharma is a clinical-stage biopharmaceutical company dedicated to designing and developing innovative therapeutics targeting the TGF-beta superfamily, specifically focusing on Activin x GDF biology. Their lead candidate, HS235, is in clinical development for treating pulmonary hypertension, heart failure, and obesity, addressing significant unmet... medical needs. The company leverages advanced protein engineering to create multi-specific ligand traps that are highly selective and potent, facilitating rapid clinical trials. With a team experienced in advancing complex biologics, 35Pharma aims to deliver transformative therapies to improve patient outcomes. Read More

Q: Who invested in 35Pharma?

35Pharma has 3 investors including Vivo Capital, Frazier Life Sciences Management and Deep Track Capital.

Q: Is 35Pharma a public company?

35Pharma is private company therefore does not currently have an official ticker symbol

Blood & Organ Banks · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

750 Boul Saint-Laurent Suite 101, Montre...

Website

www.35pharma.com

Revenue

<$5 Million

Industry

Blood & Organ Banks

Business Services

Healthcare Services

Research & Development

About 35Pharma

35Pharma is a clinical-stage biopharmaceutical company dedicated to designing and developing innovative therapeutics targeting the TGF-beta superfamily, specifically focusing on Activin x GDF biology. Their lead candidate, HS235, is in clinical development for treating pulmonary hypertension, heart failure, and obesity, addressing significant unmet medical needs. The company leverages advanced protein engineering to create multi-specific ligand traps that are highly selective and potent, facilitating rapid clinical trials. With a team experienced in advancing complex biologics, 35Pharma aims to deliver transformative therapies to improve patient outcomes.Explore more

Is this data correct?

View contact profiles from 35Pharma

SIC Code 28,283NAICS Code 32,325Show more

35Pharma Org Chart

Ilia Tikhomirov

Chief Executive Officer

Phone

Caroline McNicoll

Vice President, General Counsel

Phone

Maureen O'Connor

Chief Scientific Officer

Phone

Fernando Marcuci

Financial Controller

Phone

Get the full picture

Emma Saffman

Vice President, Intellectual Property

Phone

Get the full picture

Compare Similar Companies to 35Pharma

Compare insights from companies similar to 35Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

35Pharma

<$5M

11-50

Private

$53M

2021

Ilia TikhomirovCEO

Aceragen

$16.3M

11-50

Private

$399.4M

2021

Andrew JordanChief Financial Officer

Qureator

<$5M

11-50

Private

$6.7M

2017

Tsung-li LiuChief Technology Officer

WaveBreak

<$5M

11-50

Private

2016

Bart HendersonPresident & CEO

ValVention

<$5M

11-50

Private

2018

Arash KheradvarFounder, President & CEO

View Email Formats for 35Pharma

35Pharma Tech Stack

A closer look at the technologies used by 35Pharma

reCAPTCHA

Google

Cloudflare Website Optimization

See more technologies

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding 35Pharma

What is 35Pharma's official website?

35Pharma's official website is www.35pharma.com

What is 35Pharma's Revenue?

35Pharma's revenue is <$5 Million

What is 35Pharma's SIC code?

35Pharma's SIC: 28,283

What is 35Pharma's NAICS code?

35Pharma's NAICS: 32,325

How many employees does 35Pharma have?

35Pharma has 11-50 employees

What industry does 35Pharma belong to?

35Pharma is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services

What is 35Pharma competition?

35Pharma top competitors include: WaveBreak, ValVention, Aceragen, Qureator

What companies has 35Pharma acquired?

35Pharma has acquired the companies: NovaMin Technology, Aiolos Bio, Elsie Biotechnologies, Sierra Oncology

What technology does 35Pharma use?

Some of the popular technologies that 35Pharma uses are: reCAPTCHA, Cloudflare Website Optimization, Cloudflare CDN, WordPress.com

What does 35Pharma do?

What are 35Pharma social media links?

35Pharma Linkedin page

Who invested in 35Pharma?

35Pharma has 3 investors including Vivo Capital, Frazier Life Sciences Management and Deep Track Capital.

Is 35Pharma a public company?

35Pharma is private company therefore does not currently have an official ticker symbol

See more information about 35Pharma

35Pharma Latest Hires and Their Positions

35Pharma is expanding and recently hired new employees. Here are the latest additions to the team.

Zohar Bassevitch

Senior Director, Project Delivery

Joined Dec 1, 2025

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.